Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 89226-75-5
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15DAY
Payment Terms: L/C,D/P,T/T,D/A,MoneyGram,Western Union
Supply Ability: G,KG,TON
Appearance:: |
White To Pale Yellow Solid |
CAS NO:: |
89226-75-5 |
Molecular Formula:: |
C35H39ClN4O6 |
Molecular Weight:: |
647.16000 |
EINECS NO:: |
680-304-3 |
MDL NO:: |
MFCD00896434 |
Appearance:: |
White To Pale Yellow Solid |
CAS NO:: |
89226-75-5 |
Molecular Formula:: |
C35H39ClN4O6 |
Molecular Weight:: |
647.16000 |
EINECS NO:: |
680-304-3 |
MDL NO:: |
MFCD00896434 |
Product Description:
Product Name: Manidipine Dihydrochloride CAS NO: 89226-75-5
Synonyms:
4-(diphenylmethyl)-1-piperazinyl)ethylmethylester,dihydrochloride;
cv-4093dihydrochlorde;
franidipinehydrochloride;
Chemical & Physical Properties:
Appearance: White to pale yellow solid
Assay :≥99.00%
Boiling Point: 722℃ at 760 mmHg
Melting Point211℃ (dec.)
Water Solubility: Soluble in DMSO. Slightly soluble in water and ethanol /n
Storage: Refrigerator
Solubility: DMSO (Sparingly, Heated), Methanol (Slightly)
Safety Information:
HS Code: 2942000000
RIDADR: UN 2811 6.1/PG III
RTECS: US7975300
Hazard Class: 6.1
Packing Group: III
Manidipine Dihydrochloride is a metabolite of Manidipine (M16400), a dihydropyridine calcium channel blocker that exhibits antihypertensive properties. Manidipine 2Hcl (CV-4093) is a dihydropyridine compound and a calcium channel blocker for Ca2+ current with IC50 of 2.6 nM. IC50 value: 2.6 nMTarget: calcium channelManidipine is described to block T-type Ca2+ channels specifically and is also described to have a high selectivity for the vasculature, presenting negligible cardiodepression as compared to other Ca2+ channel antagonists. Manidipine is also described to not significantly affect norepinephrine levels, suggesting a lack of sympathetic activation with this compound. Manidipine reduces pro-inflammatory cytokines secretion in human endothelial cells and macrophages. Manidipine, unlike other third-generation dihydropyridine derived drugs, blocks T-type calcium channels present in the efferent glomerular arterioles, reducing intraglomerular pressure and microalbuminuria.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.